AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureHumanitiesInformation ScienceHealth Care
Vital CapacityForced Expiratory VolumeRespiratory Function TestsSpirometryForced Expiratory Flow RatesMaximal Midexpiratory Flow RateTotal Lung CapacityLungResidual VolumePulmonary Diffusing CapacityLung Volume MeasurementsMaximal Expiratory Flow RateLung Diseases, ObstructiveInspiratory CapacityPulmonary VentilationRespiratory MusclesFunctional Residual CapacityMaximal Expiratory Flow-Volume CurvesRespiration DisordersLung DiseasesPulmonary Disease, Chronic ObstructivePeak Expiratory Flow RateAirway ObstructionRespiratory MechanicsAsthmaInhalationBronchodilator AgentsExpiratory Reserve VolumeMaximal Voluntary VentilationDyspneaRespirationMethacholine ChloridePulmonary EmphysemaAirway ResistanceIdiopathic Pulmonary FibrosisSmokingBronchoconstrictor AgentsRespiratory ParalysisBronchial Provocation TestsBronchitisAdministration, InhalationExercise ToleranceDustTidal VolumePulmonary FibrosisLung Diseases, InterstitialNeuromuscular DiseasesScoliosisPlethysmography, Whole BodyAlbuterolPneumoconiosisScopolamine DerivativesRespiratory TherapyRespiratory Physiological PhenomenaPulmonary Gas ExchangeTime FactorsOccupational ExposureRespiratory InsufficiencyExercise TestRespiratory Tract DiseasesCystic FibrosisThoraxHeliumScleroderma, SystemicDivingCoughBreathing ExercisesOccupational DiseasesIpratropiumCross-Sectional StudiesQuadriplegiaBronchiectasisFenoterolThoracoplastyPulmonary AtelectasisLung ComplianceSeverity of Illness IndexDouble-Blind MethodBronchospirometryReference ValuesProspective StudiesOxygenAerosolsFollow-Up StudiesPlethysmographyBronchial HyperreactivityMetallurgyRespiratory SoundsPostoperative PeriodAir Pollutants, OccupationalCarbon MonoxideBronchoconstrictionTreatment OutcomeGas PoisoningCarbon DioxideSarcoidosis, PulmonaryAtropine DerivativesEmphysemaCapacity BuildingStatistics, Nonparametric
ChronicCOPDFibrosisHypertensionChanges in pulmonaryImpairmentSpirometryMean pulmonary artery pressureInterstitialAsthmaCardiacRespiratoryPatientsMeasure breathingCarbon monoxideCourse of pulmonaryArteryAbnormalOxygenDiagnosisClinicalPreoperativeDiseaseCirculationFEV1LungsDeterminantsTuberculosisFunction and lungMeasurementsAirflowAnalysesPFTsDeclineDiffusionFindingsCurrent ProceduralAbnormalitiesExpiratory
Chronic26
  • The association between low body mass index (BMI) and poor prognosis in patients with chronic obstructive pulmonary disease (COPD) is a common clinical observation. (nih.gov)
  • Ninety-three patients with severe chronic obstructive pulmonary disease (COPD) of the bronchitic (n = 74) or emphysematous type (n = 19), who all had arterial hypoxemia, underwent 2 right cardiac catheterizations in a clinical steady state, with a delay of 5 yr or more between the first and the last catheterization. (nih.gov)
  • Chronic obstructive pulmonary disease (COPD) has been known to mankind for over 200 year. (news-medical.net)
  • Retrieved on September 28, 2023 from https://www.news-medical.net/health/History-of-Chronic-Obstructive-Pulmonary-Disease.aspx. (news-medical.net)
  • Chronic obstructive pulmonary disease (COPD) is the fourth most common cause of death worldwide. (bmj.com)
  • Chronic obstructive pulmonary disease (COPD) is a major contributor to global mortality and morbidity and its worldwide prevalence is predicted to increase further. (bmj.com)
  • Information about the influence of regular physical activity on the course of chronic obstructive pulmonary disease (COPD) is scarce. (bmj.com)
  • Chronic obstructive pulmonary disease (COPD), with a prevalence in adults of 6-7%, 1 is one of the main causes of morbidity and a leading cause of death worldwide. (bmj.com)
  • Response of a) incremental shuttle walk (ISW) distance and b) Chronic Respiratory Disease Questionnaire (CRQ)-Total score to pulmonary rehabilitation (PR). (ersjournals.com)
  • Latent infection with adenovirus and respiratory syncytial virus (RSV) is associated with chronic obstructive pulmonary disease (COPD). (spandidos-publications.com)
  • Chronic obstructive pulmonary disease (COPD) is an inflammatory airway disease characterized by exacerbations, which are primarily caused by bacterial or viral infections. (spandidos-publications.com)
  • BODE-Index vs HADO-Score in Chronic Obstructive Pulmonary Disease: Which one to use in general practice? (biomedcentral.com)
  • Forced expiratory volume in one second (FEV 1 ) is used to diagnose and establish a prognosis in chronic obstructive pulmonary disease (COPD). (biomedcentral.com)
  • Forced expiratory volume in one second (FEV 1 ) is an essential measure for diagnosing chronic obstructive pulmonary disease (COPD) and in establishing its severity and prognosis. (biomedcentral.com)
  • Chronic obstructive pulmonary disease (COPD) is a chronic inflammatory lung disease that causes obstructed airflow from the lungs. (aidsmap.com)
  • It helps detect pulmonary obstruction, caused by conditions such as chronic obstructive pulmonary disease (commonly termed COPD) or asthma. (aidsmap.com)
  • A chronic dust disease of the lung arising out of employment in the Nation's coal mines, and includes coal workers' pneumoconiosis, anthracosilicosis, anthracosis, anthrosilicosis, massive pulmonary fibrosis, progressive massive fibrosis, silicosis, or silicotuberculosis, arising out of such employment. (justia.com)
  • Idiopathic pulmonary fibrosis (IPF) is a chronic lung disease that is clinically manifested by the appearance of effort dyspnea and impaired lung function. (druglib.com)
  • Specifically, we aim to develop a diagnostic support system for the very early stage of chronic obstructive pulmonary disease (COPD) based on the CT images. (scirp.org)
  • Chronic Obstructive Pulmonary Disease (COPD) is a disease added to target diseases of "Health Japan 21" planned by the Ministry of Health, Labor and Welfare as one of new lifestyle-related diseases since 2013 [1]. (scirp.org)
  • COPD, also known as "tobacco disease", is a pulmonary chronic inflammatory disease caused by long-term inhalation exposure of harmful substances, mainly tobacco smoke. (scirp.org)
  • Editorial Note: Chronic berylliosis is a pulmonary and systemic granulomatous disease caused by exposure to beryllium. (cdc.gov)
  • The combined therapy of Bufei Yishen granules (BY) and electroacupuncture (EA) has shown good effects clinically in treating chronic obstructive pulmonary disease (COPD). (hindawi.com)
  • Chronic obstructive pulmonary disease (COPD) is a common, preventable, and treatable disease characterized by persistent respiratory symptoms and airflow limitation [ 1 ]. (hindawi.com)
  • Roflumilast is being developed to treat people who have chronic obstructive pulmonary disease (COPD). (astrazenecaclinicaltrials.com)
  • An 80-year-old woman with mild chronic obstructive pulmonary disease (COPD) is referred to the pulmonologist for dyspnea. (medscape.com)
COPD6
  • Using multi-dimensional scores improves this predictive capacity.Two instruments, the BODE-index ( B ody mass index, O bstruction, D yspnea, E xercise capacity) and the HADO-score ( H ealth, A ctivity, D yspnea, O bstruction), were compared in the prediction of mortality among COPD patients. (biomedcentral.com)
  • The aim of this study was to compare the predictive capacity of the BODE-index and the HADO-score for all-cause and respiratory mortality in a large group of ambulatory patients with varying severity of COPD. (biomedcentral.com)
  • Lung cancer and obstructive pulmonary disease share multiple etiological factors, such as cigarette smoking, occupational inhalation hazards, and air pollution, and 50-70% of lung cancer patients present with co-existing COPD or airflow obstruction 6 . (nature.com)
  • Pulmonary function was markedly decreased in the COPD rats, and the lung tissue histology of the COPD rats showed severe pathological changes. (hindawi.com)
  • The objective of the REACT trial is to investigate the effect of roflumilast 500 μg tablets once daily versus placebo on exacerbation rate and pulmonary function in COPD patients who are concomitantly treated with a fixed combination of long-acting β2-agonists (LABA) and inhaled glucocorticosteroids (ICS). (astrazenecaclinicaltrials.com)
  • This study investigated the effect of roflumilast 500 μg tablets once daily versus placebo on exacerbation rate, pulmonary function, and major adverse cardiovascular events (MACE) in COPD patients who were concomitantly treated with a fixed combination of long-acting beta-agonists (LABA) and inhaled glucocorticosteroids. (astrazenecaclinicaltrials.com)
Fibrosis29
Hypertension19
  • [ 4 ] Physical examination findings may be suggestive of the presence of pulmonary hypertension. (medscape.com)
  • This investigation involved analyses of the potential for pulmonary hypertension (PH) and interstitial lung disease (ILD) to have an impact on patients living with systemic sclerosis. (ajmc.com)
  • For patients already living with systemic sclerosis, also having both pulmonary hypertension (SSc-PH) and interstitial lung disease (SSc-ILD) exacerbates their risk of all-cause mortality, and this risk only goes up with increasing severity of both comorbidities, reports a recent published study in Pulmonary Circulation . (ajmc.com)
  • The overwhelming most common first-line treatment was that specific to pulmonary arterial hypertension. (ajmc.com)
  • Clinical characteristics and outcomes in pulmonary manifestations of systemic sclerosis: Contribution from pulmonary hypertension and interstitial lung disease severity. (ajmc.com)
  • Pulmonary arterial hypertension (PAH) is a dreaded complication of systemic sclerosis (SSc) that occurs in ∼10% of patients. (ersjournals.com)
  • Pulmonary arterial hypertension (PAH) is a devastating condition that causes significant disability and often results in premature death. (ersjournals.com)
  • All patients fulfilled the 2013 American College of Rheumatology/European League Against Rheumatism criteria, had mild ILD at baseline diagnosed by High-Resolution Computed Tomography (HRCT), available baseline and ≥1 annual follow-up pulmonary function tests and no concomitant pulmonary hypertension or airflow obstruction. (bmj.com)
  • The US Food and Drug Administration (FDA) has approved treprostinil (Tyvaso) Inhalation Solution for the treatment of patients with pulmonary hypertension associated with interstitial lung disease (PH-ILD) to help improve exercise ability. (consultantlive.com)
  • The indication is the second granted by the FDA for the United Therapeutics drug, following its approved as a pulmonary arterial hypertension (PAH) therapy in July 2009. (consultantlive.com)
  • Pulmonary hypertension is estimated to affect at least 15% of patients with early-stage ILD, which is characterized as scarring in the lungs from a series of varied diseases. (consultantlive.com)
  • It also underscores our commitment to driving innovation in the field of pulmonary hypertension and expanding the number of patients who can achieve a clinical benefit from Tyvaso," Rothblatt said. (consultantlive.com)
  • Abstract Background: Pulmonary hypertension (PH) is a significant preoperative risk factor. (researchsquare.com)
  • Methods: We conducted a retrospective cohort study of adults with pulmonary hypertension having surgery at a single large medical referral center. (researchsquare.com)
  • Patients with pulmonary hypertension (PH) are at increased risk for perioperative morbidity and mortality [1-3], and PH is an independent risk factor for complications after noncardiac surgery [4]. (researchsquare.com)
  • Patients with PH, 18 years and older, were identified from the Mayo Clinic Pulmonary Hypertension database with rationale that patients in registry have complete and detailed assessments of their PH. (researchsquare.com)
  • Because of fundamental differences in pathophysiologic changes, including in right ventricular afterload in postcapillary PH, patients with established group 2 PH (pulmonary venous hypertension) were not included [12]. (researchsquare.com)
  • Despite the availability of specific therapies targeting multiple pathways involved in the development and progression of pulmonary arterial hypertension (PAH), and the improved survival observed in PAH patients in recent years, it remains a progressive, devastating disease [ 1 ]. (ersjournals.com)
  • This article reports the management of a patient diagnosed with severe PAH (New York Heart Association (NYHA) functional class IV) who was referred to the national pulmonary hypertension reference centre. (ersjournals.com)
Changes in pulmonary3
  • Using computed tomography (CT), geometrical changes in pulmonary structures in 4 human volunteers were analyzed. (karger.com)
  • Changes in pulmonary structures were evaluated by comparing the maximal inspiration scans for each slice position. (karger.com)
  • These radiographic changes did not correlate with significant changes in pulmonary function test findings or declines in physical function as measured by 6-minute walking test (6MWT), reported Stephen Goertzen, DO, of Brooke Army Medical Center in Houston. (medpagetoday.com)
Impairment7
  • Charcot-Marie-Tooth disease can be associated with several disorders that may be encountered by the pulmonary physician, including restrictive pulmonary impairment, sleep apnea, restless legs, and vocal cord dysfunction. (springer.com)
  • Restrictive pulmonary impairment has been described in association with phrenic nerve dysfunction, diaphragm dysfunction, or thoracic cage abnormalities. (springer.com)
  • For instance, bilevel positive airway pressure may be more appropriate than continuous positive airway pressure (CPAP) for the treatment of sleep apnea in the individual with concomitant restrictive pulmonary impairment. (springer.com)
  • These findings support a causal role of pulmonary impairment in lung cancer etiology. (nature.com)
  • Disentangling the role of pulmonary impairment in lung cancer development is important from an etiological perspective, for refining disease susceptibility mechanisms, and for informing precision prevention and risk stratification strategies. (nature.com)
  • Moreover, it is known that impairment of dyspnea and exercise capacity at the time of exertion is caused, impairing patient's quality of life and threatening life prognosis. (scirp.org)
  • Prior to performing spirom- widely used to estimate the degree as sites of the study: Riyadh, Mecca, etry, the procedure was explained and of pulmonary impairment in cases of Dammam, Abha, Jizan and Al-Jouf. (who.int)
Spirometry3
  • Its main objective was to compare lung function among HIV-positive and HIV-negative participants, with the use of spirometry and single-breath diffusing capacity for carbon monoxide, commonly termed DL CO in medical practice. (aidsmap.com)
  • Secondary outcomes include the individual components of the primary outcome, (1) King's Brief Interstitial Lung Disease Questionnaire, (2) MRC Dyspnoea Score, (3) EQ5D, (4) spirometry, (5) total lung-diffusing capacity and (6) routine sputum microbiology. (uea.ac.uk)
  • Two prevalent cases of abnormal spirometry were observed among participants with no history of respiratory disease: one participant had borderline obstruction and another had a mildly low vital capacity. (cdc.gov)
Mean pulmonary artery pressure1
  • Patients were divided into 2 groups according to the initial level of mean pulmonary artery pressure (Pap). (nih.gov)
Interstitial1
  • Interstitial lung disease (ILD) is the most common type of pulmonary involvement in SSc, pSS, MCTD, and RA 17 , 18 . (jrheum.org)
Asthma3
  • Patients were not eligible for the study if they had been diagnosed with asthma, had extensive pulmonary tuberculosis or neoplastic processes, were suffering from psychiatric or neurological problems that might prevent effective collaboration, or had hearing or other problems that impeded accurate communication. (biomedcentral.com)
  • Numerous studies have documented significant associations between increased respiratory symptoms, persistent airways hyperreactivity, RADS or asthma, and/or declines in pulmonary function with earlier WTC arrival times. (cdc.gov)
  • Pulmonary function tests have been Study design and sampling criteria were bronchial asthma, chest widely used as an objective measure This cross-sectional study was cage deformities, previous chest inju- to diagnose and follow up the course conducted among normal healthy ries and/or chest operation, cardiac of therapy in lung diseases. (who.int)
Cardiac4
  • The other hemodynamic parameters (pulmonary capillary wedge pressure, right ventricle filling pressure, cardiac output) did not change. (nih.gov)
  • Such symptoms can be shared with a variety of pulmonary and cardiac diseases. (medscape.com)
  • A previous study shows an association between the presence of changes on NCM and the occurrence of cardiac/pulmonary involvement in patients with SSc, independent of specific antibodies 8 . (jrheum.org)
  • Also, patients with DMD (as well as patients diagnosed with BMD) should have preoperative evaluations by pulmonary, anesthesia, and cardiac specialists prior to any surgery. (mda.org)
Respiratory5
  • Furthermore, the vital capacity is used to determine the severity of respiratory muscle involvement in neuromuscular disease, and can guide treatment decisions in Guillain-Barré syndrome and myasthenic crisis. (wikipedia.org)
  • Lung volumes and lung capacities refer to the volume of air associated with different phases of the respiratory cycle. (wikipedia.org)
  • Radiographic evidence of pulmonary pathology was common months after acute infection among people with ongoing exertional or respiratory symptoms, early results of a study exploring the physiology of long COVID showed. (medpagetoday.com)
  • Pulmonary Function Tests (PFTs) play a crucial role in evaluating lung health and diagnosing respiratory conditions. (namdrc.org)
  • Maximal inspiratory pressures and vital capacities are measurements of neuromuscular respiratory function and predict diaphragmatic strength. (medscape.com)
Patients17
  • No patients received long-term O2 therapy or pulmonary vasodilator drugs. (nih.gov)
  • DMD patients are at risk for the development of restrictive lung disease, dilated cardiomyopathy, mitral regurgitation, and recurrent pulmonary infections secondary to aspiration. (medscape.com)
  • Furthermore, reverse causality remains a concern since pulmonary symptoms may be early manifestations of lung cancer or acquired lung diseases in patients whose immune system has already been compromised by undiagnosed cancer. (nature.com)
  • To assess the presence of a systemic sclerosis (SSc) pattern on nailfold capillary microscopy (NCM) in patients with Raynaud phenomenon (RP) and to explore its association with abnormal pulmonary function tests (PFT). (jrheum.org)
  • Our aim was to describe the presence of SSc patterns on NCM in a large cohort of consecutive patients with RP visiting the vascular laboratory for NCM in our tertiary referral center, and to explore whether a possible association exists between NCM patterns and abnormal pulmonary function tests (PFT). (jrheum.org)
  • Symptomatic patients, those with an elevated tricuspid regurgitation velocity on echocardiogram with or without secondary echocardiographic features of PAH, and those who screen positive on the DETECT or other pulmonary function test algorithms should undergo right heart catheterisation. (ersjournals.com)
  • Diffuse cutaneous subset, presence of antitopoisomerase-I antibodies, decreased baseline forced vital capacity (FVC) and diffusing capacity for carbon monoxide (DLCO) were reported to be significantly associated with lung progression in patients with SSc, while positive anticentromere antibody (ACA) was protective. (bmj.com)
  • Our results demonstrate that positive RI-SUV is strongly predictive of earlier deterioration of pulmonary function and higher mortality in patients with IPF. (snmjournals.org)
  • Also, pulmonary 18 F-FDG uptake was recently reported to be a predictor of global health score and lung physiology in patients with IPF ( 11 ). (snmjournals.org)
  • The supplemental approval for Tyvaso comes on the basis of clinical evidence showing benefit for pulmonary and cardiovascular outcomes in adult patients. (consultantlive.com)
  • Patients additionally benefitted in placebo-corrected forced vital capacity (FVC) improvements, and reported significantly fewer underlying lung disease exacerbations. (consultantlive.com)
  • Fully 55% of the subset of persistently symptomatic patients with a high-resolution CT showed radiographic evidence of pulmonary pathology at least 3 months post-infection in an 80-patient interim analysis of a study exploring the physiology of long COVID. (medpagetoday.com)
  • At total of 32 of the 591 clinic patients (59% female, average age 56 years) underwent at least two rounds of pulmonary function testing, and these patients were included in the analysis presented by Amy Ludwig, MD, of Northwestern University's McGaw Medical Center in Chicago. (medpagetoday.com)
  • After 48 weeks, decline in lung function from baseline, as defined by changes in predicted forced vital capacity (FVC), had occurred 50.5% of patients in the tocilizumab arm, versus 70.3% of those in the placebo arm ( P = 0.015). (medscape.com)
  • The median age was 27.5 years, and median forced vital capacity was at 10% of the predicted value: 83 patients (92%) were on home mechanical ventilation. (bvsalud.org)
  • Admission to the intensive care unit (ICU) should be considered for all patients with labile dysautonomia, a forced vital capacity of less than 20 mL/kg, or severe bulbar palsy. (medscape.com)
  • Subcutaneous unfractionated or low ̶ molecular-weight heparin (LMWH) and thromboguards are often used in the treatment of immobile patients to prevent lower-extremity deep venous thrombosis (DVT) and consequent pulmonary embolism (PE). (medscape.com)
Measure breathing1
  • Pulmonary function tests are a group of tests that measure breathing and how well the lungs are functioning. (ucsfhealth.org)
Carbon monoxide4
  • The current threshold values used to define "significant decline" are a reduction from baseline values of 10% for forced vital capacity (FVC) and 15% for diffusing capacity of the lung for carbon monoxide ( D L,CO ) 1 . (ersjournals.com)
  • Other options for screening include the DETECT algorithm or the use of a combination of pulmonary function testing (forced vital capacity/diffusing capacity of the lung for carbon monoxide ratio) and N-terminal-pro-brain natriuretic peptide levels. (ersjournals.com)
  • ILD progression was defined as a relative decrease in forced vital capacity (FVC)%≥15%, or FVC%≥10% combined with diffusing capacity for carbon monoxide %≥15% at 1-year follow-up. (bmj.com)
  • Significant improvements in lung function included those in forced vital capacity (FVC), TLC and diffusion capacity of carbon monoxide (DLCO), but not forced expiratory volume at one second (FEV 1 ) in the year following acute COVID-19 illness. (medpagetoday.com)
Course of pulmonary1
  • 13 Studies in both cohorts (FDNY and non-FDNY) are currently underway to determine the course of pulmonary function over the next 5 years post-WTC, specifically, whether it has improved, stabilized or declined, and, if there are differences in clinical course within or between the cohorts, and which factors might be predictive of favorable or unfavorable outcome. (cdc.gov)
Artery1
  • 3 Wood units and normal left heart pressures (pulmonary artery wedge and/or left ventricular end-diastolic pressure ≤15 mmHg) [ 2 ]. (ersjournals.com)
Abnormal2
  • According to a US study in the 1 July issue of AIDS , HIV-positive men are at a higher risk of abnormal pulmonary gas exchange than HIV-negative men. (aidsmap.com)
  • In the NY/NJ consortium report on 8,384 non-FDNY workers/volunteers, 28% had abnormal pulmonary function test results 13 . (cdc.gov)
Oxygen5
  • The work of Paul Bert, who demonstrated the toxic effects of oxygen (producing generalized seizures), as well as the work of J. Lorrain-Smith, who demonstrated pulmonary oxygen toxicity, were used with Navy divers. (medscape.com)
  • Oxygen therapy and pulmonary rehabilitation also developed over the last half of the 20th century. (news-medical.net)
  • Pulmonary Function Testing (PFT) Pulmonary function tests measure the lungs' capacity to hold air, to move air in and out, and to absorb oxygen. (merckmanuals.com)
  • Expiratory flow limitation and the response to breathing a helium-oxygen gas mixture in a canine model of pulmonary emphysema. (jci.org)
  • During forced vital capacity deflation, in an open-chest preparation, maximum expiratory flow, choke-point locations, and the response to breathing an 80:20 helium/oxygen gas mixture were determined at multiple lung volumes. (jci.org)
Diagnosis1
Clinical1
  • The BCR, established at the Massachusetts Institute of Technology in 1952 to collect data and to study the clinical course, treatment, and complications of beryllium disease (4), was maintained by the Pulmonary Unit of the Massachusetts General Hospital through 1977. (cdc.gov)
Preoperative1
  • Test of pulmonary function was performed on preoperative day and postoperative day 4. (sages.org)
Disease4
  • The vital capacity can be used to help differentiate causes of lung disease. (wikipedia.org)
  • In restrictive lung disease the vital capacity is decreased. (wikipedia.org)
  • Although these data need validation in a prospective setting, they underline the importance of NCM in RP and putative value to stratify the risk of pulmonary involvement in early stages of disease. (jrheum.org)
  • As Aaron Waxman, MD, PhD, Director of the Pulmonary Vascular Disease Program at Brigham and Women's Hospital and the chair of the INCREASE Study Steering Committee, said in a statement , adults living with PH-ILD generally experience a poorer quality of life, increased shortness of breath, poor exercise tolerance, and higher risk of mortality. (consultantlive.com)
Circulation1
  • Pathologically, PAH is characterised by proliferative remodelling of the small pulmonary arteries, which increases resistance to blood flow through the pulmonary circulation [ 1 ]. (ersjournals.com)
FEV11
  • Forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) were significantly higher in males than females. (who.int)
Lungs3
  • Vital capacity (VC) is the maximum amount of air a person can expel from the lungs after a maximum inhalation. (wikipedia.org)
  • These tests measure how well the lungs work, providing vital information about lung volume, capacity, rates of flow, and gas exchange. (namdrc.org)
  • Pulmonary Function Tests (PFTs) are a group of tests that measure how well your lungs work. (namdrc.org)
Determinants1
  • In this study we comprehensively assess the shared genetic basis of impaired lung function and lung cancer risk by conducting genome-wide association analyses in the UK Biobank cohort to identify genetic determinants of three pulmonary phenotypes, forced expiratory volume in 1s (FEV 1 ), forced vital capacity (FVC), and FEV 1 /FVC. (nature.com)
Tuberculosis1
  • Droplet nuclei are produced when persons with pulmonary tuberculosis cough, sneeze, speak, or sing. (cdc.gov)
Function and lung1
  • The pulmonary function and lung tissue morphology in the treatment groups (APL, BY, EA, and BY + EA) were improved. (hindawi.com)
Measurements1
  • Data were obtained through a questionnaire, pulmonary function testing and taking anthropometric measurements. (who.int)
Airflow1
Analyses1
  • Integrative analyses reveal that pulmonary function instruments, including 73 novel variants, influence lung tissue gene expression and implicate immune-related pathways in mediating the observed effects on lung carcinogenesis. (nature.com)
PFTs3
  • What are Pulmonary Function Tests (PFTs)? (namdrc.org)
  • Compliance with coding guidelines and regulations is vital when performing PFTs. (namdrc.org)
  • What is the role of a medical coder in Pulmonary Function Tests (PFTs)? (namdrc.org)
Decline2
Diffusion1
  • To measure diffusion capacity , you breathe a harmless gas, called a tracer gas, for a very short time, often for only one breath. (ucsfhealth.org)
Findings1
Current Procedural1
  • The Current Procedural Terminology (CPT) code range for Pulmonary Procedures 94010-94799 is a medical code set maintained by the American Medical Association. (aapc.com)
Abnormalities1
  • Pulmonary function declines or abnormalities have been significantly related to WTC exposure intensity (based on arrival time) in FDNY and non-FDNY workers. (cdc.gov)
Expiratory2